B
A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. INC. 2024 Best Workplaces #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #lifesciences #diagnostics
Investor insights
Funding rounds participated in
$55M sweet spot round size
Investor type
Public Company
Basic info
Industry
Hospitals and Health Care
Sectors
Hospitals and Health Care
Date founded
2005
Funding rounds raised
Total raised
$55M
from investors over 1 rounds
B
Biodesix, Inc. raised $55M on May 5, 2024